专利号:US-2024400576-A1 优先权日:2021-09-03 标 题:Nitrogen-containing derivatives of salinomycin, synthesis and uses thereof 发明人:RODRIGUEZ RAPHAËL; CZERWONKA DOMINIKA; ANTOSZCZAK MICHAL; HUCZYNSKI ADAM 权利人:CENTRE NAT RECH SCIENT; INST CURIE; INST NAT SANTE RECH MED; ADAM MICKIEWICZ UNIV 摘要:The present invention relates to nitrogen-containing derivatives of salinomycin having the formula (I), as well as pharmaceutically acceptable salt thereof, and synthesis and uses thereof, in particular for the treatment and/or prevention of cancer including for preventing cancer metastasis and/or for preventing cancer recurrence and/or for decreasing resistance to a chemotherapy in a subject.
专利号:US-2025250280-A1 优先权日:2021-09-03 标 题 :Nitrogen-containing derivatives of narasin, synthesis and uses thereof 发明人:RODRIGUEZ RAPHAËL; CAÑEQUE TATIANA; MÜLLER SEBASTIAN; ANTOSZCZAK MICHAL 权利人:CENTRE NAT RECH SCIENT; INST NAT SANTE RECH MED; INST CURIE 摘要:The present invention relates to nitrogen-containing derivatives of narasin having the formula (I), as well as synthesis and uses thereof, in particular for the treatment and/or prevention of cancer. Also disclosed are medicaments including the nitrogen-containing derivatives of narasin, which include medicaments for preventing cancer metastasis and/or for preventing cancer recurrence and/or for decreasing resistance to a chemotherapy in a subject.
专利号:US-2024360247-A1 优先权日:2021-08-10 标 题:Compositions and methods for treatment of cancer 发明人:CHATTERJEE SUBROTO 权利人:UNIV JOHNS HOPKINS 摘要:Compositions in the prevention and treatment of cancers, such as colorectal cancer or diseases associated with abnormal levels of β-1,4-galactosyltransferase-V (β-1,4-GalT-V), include at least one inhibitor of glycosphingolipid synthesis.
专利号:US-11781178-B2 优先权日:2017-12-15 标题:Methods and compositions for the amplification of mRNA 发明人:DECKER WILLIAM K; KONDURI VANAJA 权利人:BAYLOR COLLEGE MEDICINE 摘要:Provided herein are compositions and methods for the synthesis, amplification, and in vitro transcription of full-length cDNA, or cDNA fragments. Methods are provided for reverse transcription of RNA and amplification for in vitro transcription. Further provided are method for loading of dendritic cells with the RNA and homologous lysate for immune stimulation.
专利号:WO-2024117980-A1 优先权日:2022-12-02 标题 :Compounds for modulating src family kinases and uses thereof 发明人:KUMAR ALAN PREM; SETHI GAUTAM; LEE E HUI CLARISSA; - BASAPPA; RANGAPPA KANCHUGARAKOPPAL S; MOHAN CHAKRABHAVI DHANANJAYA 权利人:NAT UNIV SINGAPORE; UNIV OF MYSORE 摘要:The present invention relates to chalcone (CHL) compounds, their synthesis, and applications in modulating the activity of Src Family Kinases (SFKs), specifically Lyn kinase, and methods of use in treating various diseases and conditions associated with aberrant activity of Src Family Kinases.
专利号:US-9295731-B2 优先权日:2013-04-01 标题 :Cleavable drug conjugates, compositions thereof and methods of use 发明人:NGUYEN MARK QUANG 权利人:NGUYEN MARK QUANG 摘要:Base-labile crosslinkers, base-labile conjugates comprising such crosslinkers, methods of their synthesis and use are disclosed.
1: Vidal SI, Menta N, Friedman A. To Acne and Beyond: A Review of Sarecycline's Off-Label Uses. J Drugs Dermatol. 2024 Sep 1;23(9):792-793. 39(9):e4889. doi: 10.1002/bio.4889. 17(6):50-54. 5: Baldwin HE, Graber E, Harper JC, Alexis AF, Stein Gold L, Kircik L, Del Rosso J, Hebert AA, Rieder EA, Fried RG, Narayanan S, Koscielny V, Kasujee I. INDIVIDUAL ARTICLE: Sarecycline Improves Acne Severity, Symptoms, and Psychosocial Burden in Non-nodular Acne Vulgaris: PROSES Study. J Drugs Dermatol. 2024 Feb 1;23(2):SF405634s12-SF405634s18. doi: 10.36849/JDD.SF405634. 23(2):SF405634s5-SF405634s11. doi: 10.36849/JDD.SF405634. 23(2):e55-e56. doi: 10.36849/JDD.7638. 90(5):1006.e1-1006.e30. doi: 10.1016/j.jaad.2023.12.017. Epub 2024 Jan 30. 66(1695):17-20. doi: 10.58347/tml.2024.1695a. 77(4):230-234. doi: 10.2533/chimia.2023.230. 79(1):96-99. doi: 10.1093/jac/dkad352. 12: Poplausky D, Young JN, Dubin DP, Tremblay D, Gulati N. Dasatinib-Associated Acneiform Eruption Successfully Treated With Sarecycline in a Patient With Chronic Myeloid Leukemia. Cureus. 2023 Sep 21;15(9):e45697. doi: 10.7759/cureus.45697.
合成参考文献
参考文献:10.3816/clc.2006.n.020 摘要:Lee D, Gautschi O. Clinical development of SRC tyrosine kinase inhibitors in lung cancer. Clin Lung Cancer. 2006 May;7(6):381–4. doi: 10.3816/clc.2006.n.020. 参考文献:10.1007/s10549-008-9997-1 摘要:Jones RJ, Young O, Renshaw L, Jacobs V, Fennell M, Marshall A, Green TP, Elvin P, Womack C, Clack G, Dixon JM. Src inhibitors in early breast cancer: a methodology, feasibility and variability study. Breast Cancer Research and Treatment. 2008 Apr 14;114(2):211–21. doi: 10.1007/s10549-008-9997-1. 参考文献:10.4161/cbt.12.3.16218 摘要:Mitchell C, Hamed HA, Cruickshanks N, Tang Y, Bareford MD, Hubbard N, Tye G, Yacoub A, Dai Y, Grant S, Dent P. Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death. Cancer Biol Ther. 2011 Aug 01;12(3):215–28. 参考文献:10.1186/bcr3650 摘要:Formisano L, Nappi L, Rosa R, Marciano R, D’Amato C, D’Amato V, Damiano V, Raimondo L, Iommelli F, Scorziello A, Troncone G, Veneziani BM, Parsons SJ, De Placido S, Bianco R. RETRACTED ARTICLE: Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. Breast Cancer Res. 2014 May 05;16(3). doi: 10.1186/bcr3650. 参考文献:10.1002/pros.23119 摘要:Posadas EM, Ahmed RS, Karrison T, Szmulewitz RZ, O'Donnell PH, Wade JL, Shen J, Gururajan M, Sievert M, Stadler WM. Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study. Prostate. 2016 Feb 15;76(3):286–93.